COVID-19 in MS: Initial observations from the Pacific Northwest

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is marked by a wide range and severity of symptoms. Most patients have mild to moderate symptoms, whereas 10%–15% require hospitalization. Mortality is higher with cardiovascular disorders, diabetes, and older age.1

Source: Neurology Neuroimmunology and Neuroinflammation - May 25, 2020 Category: Neurology Authors: Bowen, J. D., Brink, J., Brown, T. R., Lucassen, E. B., Smoot, K., Wundes, A., Repovic, P. Tags: All Clinical Neurology, Viral infections, Multiple sclerosis Clinical/Scientific Notes Source Type: research